Thursday, May 10, 2018 7:27:27 AM
The previous link doesn't work anymore that discusses the 1st 11 EGFR pts and reference to Nature Medicine but this link works
https://www.onclive.com/inside-oncology/nsclc-targeting-egfr/further-research-investigating-poziotinib-in-nsclc
While I'm at it, here's the video link from earlier this week where Dr Heymach mentions that the exon 20 insertion mutation can be found in 20 other cancer indications and it will double the # of patients with this mutation (i.e. to a total of about 40,000).
There's actually a third 3 min Dr Heymach video out there that I checked out but can't find at the moment but if you got these other 2 links then the 3 min video is nothing special.
Recent SPPI News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 11/09/2023 10:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:27 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/26/2023 09:23:08 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM